Author Topic: Pfizer-BioNTech effectiveness down to 42% Moderna down to 76%  (Read 1355 times)

admin

  • Administrator
  • Hero Member
  • *****
  • Posts: 3090
Pfizer-BioNTech effectiveness down to 42% Moderna down to 76%
« on: August 28, 2021, 10:37:20 AM »
https://www.visiontimes.com/2021/08/13/pfizer-vaccine-42-effective.html

"A new preprint study published on Aug. 8, 2021 in medRxiv examined the effectiveness of the Pfizer-BioNTech and Moderna mRNA vaccines in the Mayo Clinic Health System spanning Arizona, Florida, Iowa, Minnesota, and Wisconsin, from January to July 2021. During this time, “either the Alpha or Delta variant was highly prevalent.”

The retrospective study included individuals older than 18 years who had never had a positive SARS-CoV-2 PCR test prior to their first vaccine dose, and had not received a mismatched series of vaccines. 119,463 individuals met the criteria for the Pfizer-BioNTech group, and 60,083 individuals met the criteria for the Moderna group.

The initial results were promising. During the study period, the Moderna and Pfizer-BioNTech vaccines were 86% and 76% effective, respectively, at preventing SARS-CoV-2 viral infection. Moderna was 91.6% effective at preventing Coronavirus Disease 2019 (COVID-19) associated hospitalization, while Pfizer-BioNTech was 85% effective.

However, the effectiveness against infection plummeted in July, with 76% efficacy for Moderna and 42% efficacy for Pfizer-BioNTech. Of note, “the Delta variant prevalence in Minnesota increased from 0.7% in May to over 70% in July whereas the Alpha variant prevalence decreased from 85% to 13% over the same time period.”

The authors also concluded that “the rates of complications experienced by patients with breakthrough infections were similar between those vaccinated with mRNA-1273 [Moderna] or BNT162b2 [Pfizer-BioNTech].”

Potential complications included “acute respiratory distress syndrome/acute lung injury (ARDS/ALI), acute kidney injury, anemia, cardiac arrest, cardiac arrhythmias, disseminated intravascular coagulation, heart failure, hyperglycemia, hypertension, myocardial infarction, pleural effusion, pulmonary embolism, respiratory failure, sepsis, septic shock, stroke/cerebrovascular accident, venous thromboembolism, encephalopathy/delirium, and numbness.”"
_______________________________________________

So does this mean that those that get the booster are only going to get 42% effectiveness (or as the Delta variant sweeps the U.S. perhaps sinking down to 17% as in Israel) since the original alpha virus that the vaxx was designed to mitigate barely exists any more? Might boosters essentially be Big Pharma dumping their left over stock into people's arms at taxpayer expense?

Very important video at this link: https://uncanceled.news/here-is-the-video-by-dr-peter-mccullough-that-is-changing-minds-about-the-vaccines/
« Last Edit: September 01, 2021, 11:19:30 AM by admin »
www.covidtreatmentoptions.com/
Over a million Americans died completely unnecessary, horrific, deaths from COVID-19. Do you have a plan in place to help your family dodge the average $73,300 COVID hospital bill, through prevention and $20 EARLY treatment? https://www.covidtreatment

admin

  • Administrator
  • Hero Member
  • *****
  • Posts: 3090
Re: Pfizer-BioNTech effectiveness down to 42% Moderna down to 76%
« Reply #1 on: September 27, 2021, 07:23:34 AM »
bump
www.covidtreatmentoptions.com/
Over a million Americans died completely unnecessary, horrific, deaths from COVID-19. Do you have a plan in place to help your family dodge the average $73,300 COVID hospital bill, through prevention and $20 EARLY treatment? https://www.covidtreatment